Home-based multidisciplinary interventions on skin adverse reactions in EGFR-TKI-treated patients with lung cancer: a protocol for a randomised controlled trial.
Ruofei DuHuashan YangHuiyue ZhouLixia MaMikiyas Amare GetuChangying ChenTao WangPublished in: BMJ open (2022)
Chinese Clinical Trials Registry (ChiCTR2000040643).
Keyphrases
- tyrosine kinase
- clinical trial
- epidermal growth factor receptor
- small cell lung cancer
- advanced non small cell lung cancer
- randomized controlled trial
- physical activity
- soft tissue
- wound healing
- phase ii
- quality improvement
- open label
- adverse drug
- chronic myeloid leukemia
- newly diagnosed
- emergency department
- electronic health record